ALERS Statistics

Total Valuation

Eurobio Scientific Société anonyme has a market cap or net worth of EUR 247.58 million. The enterprise value is 259.21 million.

Market Cap	247.58M
Enterprise Value	259.21M

Important Dates

The next estimated earnings date is Tuesday, September 24, 2024.

Earnings Date	Sep 24, 2024
Ex-Dividend Date	n/a

Share Statistics

Eurobio Scientific Société anonyme has 10.04 million shares outstanding. The number of shares has increased by 0.06% in one year.

Shares Outstanding	10.04M
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	-20.37%
Owned by Insiders (%)	0.17%
Owned by Institutions (%)	4.96%
Float	5.51M

Valuation Ratios

The trailing PE ratio is 57.33 and the forward PE ratio is 25.95.

PE Ratio	57.33
Forward PE	25.95
PS Ratio	2.10
PB Ratio	1.41
P/FCF Ratio	10.90
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.65, with an EV/FCF ratio of 11.41.

EV / Earnings	53.61
EV / Sales	1.98
EV / EBITDA	13.65
EV / EBIT	25.56
EV / FCF	11.41

Financial Position

The company has a current ratio of 2.72, with a Debt / Equity ratio of 57.46.

Current Ratio	2.72
Quick Ratio	2.26
Debt / Equity	57.46
Debt / EBITDA	5.30
Debt / FCF	4.43
Interest Coverage	2.33

Financial Efficiency

Return on equity (ROE) is 2.78% and return on invested capital (ROIC) is 2.25%.

Return on Equity (ROE)	2.78%
Return on Assets (ROA)	1.96%
Return on Capital (ROIC)	2.25%
Revenue Per Employee	435,487
Profits Per Employee	16,117
Employee Count	300
Asset Turnover	0.40
Inventory Turnover	3.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.70% in the last 52 weeks. The beta is -0.28, so Eurobio Scientific Société anonyme's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	-30.70%
50-Day Moving Average	19.42
200-Day Moving Average	16.66
Relative Strength Index (RSI)	85.92
Average Volume (20 Days)	21,276

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Eurobio Scientific Société anonyme had revenue of EUR 130.65 million and earned 4.84 million in profits. Earnings per share was 0.43.

Revenue	130.65M
Gross Profit	51.58M
Operating Income	10.14M
Pretax Income	6.98M
Net Income	4.84M
EBITDA	18.99M
EBIT	10.14M
Earnings Per Share (EPS)	0.43

Full Income Statement

Balance Sheet

The company has 89.03 million in cash and 100.66 million in debt, giving a net cash position of -11.63 million or -1.16 per share.

Cash & Cash Equivalents	89.03M
Total Debt	100.66M
Net Cash	-11.63M
Net Cash Per Share	-1.16
Equity (Book Value)	175.17M
Book Value Per Share	17.44
Working Capital	91.03M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 26.77 million and capital expenditures -4.05 million, giving a free cash flow of 22.71 million.

Operating Cash Flow	26.77M
Capital Expenditures	-4.05M
Free Cash Flow	22.71M
FCF Per Share	2.26

Full Cash Flow Statement

Margins

Gross margin is 39.48%, with operating and profit margins of 7.76% and 3.70%.

Gross Margin	39.48%
Operating Margin	7.76%
Pretax Margin	5.34%
Profit Margin	3.70%
EBITDA Margin	14.53%
EBIT Margin	7.76%
FCF Margin	17.39%

Dividends & Yields

Eurobio Scientific Société anonyme does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.06%
Shareholder Yield	-0.06%
Earnings Yield	1.74%
FCF Yield	9.17%

Stock Splits

The last stock split was on September 1, 2017. It was a reverse split with a ratio of 0.05.

Last Split Date	Sep 1, 2017
Split Type	Reverse
Split Ratio	0.05